Abivax SA: Strong Progress in Phase 3 Trials and Solid Financial Position Justify Buy Rating
JMP Securities analyst Jason Butler reiterated a Buy rating on Abivax SA Sponsored ADR (ABVX – Research Report) today and set a price target of ...
JMP Expects a ‘Value-Creating Year’ for These 2 High-Yield Dividend Stocks
Every investor is in the markets to find a return, and there are as many investing strategies as there are investors. Some prefer to play ...
The Armenian Reporter23h
Bragg Gaming Group (NASDAQ:BRAG) Given New $5.00 Price Target at JMP Securities
Bragg Gaming Group (NASDAQ:BRAG – Free Report) had its price target lowered by JMP Securities from $6.00 to $5.00 in a research note published on Monday,Benzinga reports. The firm currently has a ...
Hosted on MSN1d
JMP Securities Initiates Coverage of Context Therapeutics (CNTX) with Market Outperform Recommendation
Fintel reports that on January 8, 2025, JMP Securities initiated coverage of Context Therapeutics (NasdaqCM:CNTX) with a ...